Glucagon and kidney effects in healthy males
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests how the hormone glucagon affects kidney function in healthy men. It may help researchers understand how glucagon works in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 20 and 60 years old.
- You are in generally good health.
- You have normal blood sugar, cholesterol, and kidney function.
- You do not take any medications that affect insulin or heart function, including steroids, lithium, or certain diabetes drugs.
- You have no history of alcohol abuse.
- You have not taken immunosuppressive drugs in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special MRI scan to see how a hormone called glucagon affects blood flow in your kidneys. Healthy volunteers will help researchers understand how the kidneys work, which may lead to better treatments for kidney disease.
This study looks at how people with fatty liver and type 2 diabetes respond to glucagon, a hormone that helps control blood sugar. It may help researchers understand a condition called 'glucagon resistance' and find better treatments.
This study looks at how the liver handles insulin and glucagon, two hormones that control blood sugar. It is for healthy adults to help researchers understand normal liver function.
This study looks at how glucagon affects insulin release and blood sugar in people who do not have type 2 diabetes. It may help us understand normal glucose control better.
This study looks at how the hormone glucagon affects blood sugar in people who have had gastric bypass or sleeve gastrectomy surgery more than a year ago, compared to people who have not had any gastrointestinal surgery. It aims to understand glucose metabolism better and may help improve care for people after bariatric surgery.
This study tests HRS-7535, a new oral tablet that may help protect kidneys in people with chronic kidney disease. GLP-1 medications were originally developed for diabetes but may also benefit kidney function and overall health.
Hear when a new Kidney Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.